Carcinoembryonic antigen and recurrence in survival of patients with resection of colorectal cancer
DOI:
https://doi.org/10.15381/anales.v75i2.8377Keywords:
Carcinoembryonic antigen, recurrence, survivalAbstract
Introduction: Carcinoembryonic antigen (CEA) has been associated with advanced stage, poor survival and early detection of recurrent colorectal cancer (CRC). Objectives: To determine relation between serum CEA and recurrence and survival of patients with curative resection of colorectal cancer. Design: Retrospective, correlational and explanatory study. Setting: Department of General and Oncology Surgery, Service of Colon and Rectum, Hospital Nacional Rebagliati Martins, EsSalud, Lima, Peru. Participants: Patients with curative resection of CRC. Methods: Patients with curative resection of CRC at Rebagliati Hospital during years 2000-2003 were followed until 2010. For variables quantitative comparison T test mean differences was used, and Kaplan-Meier method and Cox regression survival analysis techniques were used. Main outcome measures: Patients recurrence and survival. Results: Increased serum CEA in the pre and postoperative periods was related to significant increased recurrence of colorectal cancer (p <0.05). Survival in patients with pathological CEA was significantly lower than in patients with standard CEA (p <0.05). Conclusions: Elevated serum carcinoembryonic antigen was related to increased colorectal cancer recurrence. Serum CEA values in the preoperative period would be predictive of survival.Downloads
Published
2014-06-16
Issue
Section
Trabajos originales
License
Copyright (c) 2014 Jorge Renato Cribilleros Barrenechea, Teófilo Herrera Solís, Jorge Luis Arroyo Acevedo
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
- Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
- Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
- Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).
How to Cite
1.
Cribilleros Barrenechea JR, Herrera Solís T, Arroyo Acevedo JL. Carcinoembryonic antigen and recurrence in survival of patients with resection of colorectal cancer. An Fac med [Internet]. 2014 Jun. 16 [cited 2024 Jul. 17];75(2):137-43. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/8377